Showing results (101-110 of 5,322) with videos related to
Sort By:
Pageof 533
European Journal of Cancer (Oxford, England : 1990)|May 8, 2024
Health-related quality of life in trials with high rates of early censoring: Caution advisedTimothée Olivier, Alyson Haslam, Vinay PrasadNature Reviews. Clinical Oncology|October 12, 2023
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is neededAnushka Walia, Jordan Tuia, Vinay PrasadJAMA Network Open|June 26, 2023
Scoping Review of Published Oncology Meta-analyses in High-Impact Oncology JournalsAlyson Haslam, Jordan Tuia, Vinay PrasadSeminars in Oncology|May 15, 2016
ASCO Plenary Sessions: impact, legacy, futureAndrae Vandross, Vinay Prasad, Sham MailankodyThe Lancet. Oncology|February 13, 2016
Precision oncology: origins, optimism, and potentialVinay Prasad, Tito Fojo, Michael BradaInternational Journal of Cancer|January 31, 2025
How many people in the US are eligible for and respond to checkpoint inhibitors: An empirical analysisAlyson Haslam, Timothée Olivier, Vinay PrasadJournal of Cancer Policy|November 10, 2024
Analysis of 810 tweets from 25 unofficial ASCO representatives (Featured Voices) at ASCO 2024Owen Stratton, Alyson Haslam, Vinay PrasadEuropean Journal of Cancer (Oxford, England : 1990)|July 13, 2022
Dose modification rules and availability of growth factor support: A cross-sectional study of head-to-head cancer trials used for US FDA approval from 2009 to 2021Timothée Olivier, Alyson Haslam, Vinay PrasadJAMA Network Open|December 14, 2021
Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of ActionTimothée Olivier, Alyson Haslam, Vinay PrasadCancer Reports (Hoboken, N.J.)|November 25, 2021
The frequency of assessment of progression in randomized oncology clinical trialsAlyson Haslam, Jennifer Gill, Vinay PrasadPageof 533